Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed

Nature Medicine volume 25, pages 1467–1468 (2019)Cite this article

Subjects

An Author Correction to this article was published on 12 November 2019

This article has been updated

As artificial intelligence moves into the realm of clinical trials, consideration is needed on whether the current CONSORT and SPIRIT reporting statements are sufficient to ensure transparency.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 12 November 2019

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

References

  1. US Food and Drug Administration. Artificial Intelligence and Machine Learning in Software as a Medical Device (accessed 18 September 2019). https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-software-medical-device

  2. Chalmers, I., Glasziou, P., Heneghan, C., Shepperd, S., Loudon, K. & Bossuyt, P. M. Avoidable waste in the production and reporting of research evidence. Lancet 374, 86–89 (2009).

    Article  Google Scholar 

  3. Schulz, K. F., Altman, D. G. & Moher, D., for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int. J. Surg. 9, 672–677 (2011).

    Article  Google Scholar 

  4. Chan, A. W., Tetzlaff, J. M., Altman, D. G., Dickersin, K. & Moher, D. SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet 381, 91–92 (2013).

    Article  Google Scholar 

  5. EQUATOR Network. Reporting guidelines under development (EQUATOR Network, accessed 4 August 2019); http://www.equator-network.org/library/reporting-guidelines-under-development/

  6. Collins, G. S. & Moons, K. G. M. Reporting of artificial intelligence prediction models. Lancet 393, 1577–1579 (2019).

    Article  Google Scholar 

Download references

Acknowledgements

This initiative is funded by the Wellcome Trust, Health Data Research UK and the Alan Turing Institute.

Author information

Authors and Affiliations

  1. Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

    Xiaoxuan Liu & Alastair K. Denniston

  2. University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

    Xiaoxuan Liu & Alastair K. Denniston

  3. Health Data Research UK, London, UK

    Xiaoxuan Liu, Christopher Holmes & Alastair K. Denniston

  4. Moorfields Eye Hospital NHS Foundation Trust, London, UK

    Xiaoxuan Liu & Livia Faes

  5. Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

    Samantha Cruz Rivera, Melanie J. Calvert & Alastair K. Denniston

  6. Department of Ophthalmology, Cantonal Hospital Lucerne, Lucerne, Switzerland

    Livia Faes

  7. Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

    Lavinia Ferrante di Ruffano & Jonathan Deeks

  8. Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK

    Christopher Yau

  9. Alan Turing Institute, London, UK

    Christopher Yau, Sebastian J. Vollmer & Christopher Holmes

  10. National Institute of Health Research BRC for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London, UK

    Pearse A. Keane & Alastair K. Denniston

  11. Patient Safety Translational Research Centre, Imperial College London, London, UK

    Hutan Ashrafian & Ara Darzi

  12. University of Warwick, Coventry, UK

    Sebastian J. Vollmer

  13. Medignition, Zurich, Switzerland

    Lucas Bachmann

  14. Department of Medicine, Women’s College Research Institute, Women’s College Hospital, University of Toronto, Toronto, Ontario, Canada

    An Wen Chan

  15. Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada

    David Moher

  16. School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada

    David Moher

Consortia

The CONSORT-AI and SPIRIT-AI Steering Group

  • Xiaoxuan Liu
  • , Samantha Cruz Rivera
  • , Livia Faes
  • , Lavinia Ferrante di Ruffano
  • , Christopher Yau
  • , Pearse A. Keane
  • , Hutan Ashrafian
  • , Ara Darzi
  • , Sebastian J. Vollmer
  • , Jonathan Deeks
  • , Lucas Bachmann
  • , Christopher Holmes
  • , An Wen Chan
  • , David Moher
  • , Melanie J. Calvert
  •  & Alastair K. Denniston

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

The CONSORT-AI and SPIRIT-AI Steering Group. Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed. Nat Med 25, 1467–1468 (2019). https://doi.org/10.1038/s41591-019-0603-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-019-0603-3

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing